SCHEMBL7122824

SCHEMBL7122824

Cc1nccc(-c2cccc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)c2)n1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.58
SMN1; SMN2 Q16637 5/20 0.58
MAPT P10636 3/20 0.58
MAPK1 P28482 3/20 0.58
RORC P51449 3/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
CYP3A4 P08684 2/20 0.58
LMNA P02545 1/20 0.58
TP53 P04637 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
PKM P14618 1/20 0.58
TSHR P16473 1/20 0.58
NFKB1 P19838 1/20 0.58
CYP2C19 P33261 1/20 0.58
THPO P40225 1/20 0.58
MTOR P42345 1/20 0.58
PMP22 Q01453 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7128352 0.80 RORC (0.81) PPARGSMN1; SMN2MAPTMAPK1RORC
SCHEMBL7129830 0.80 PPARG (0.59) PPARGSMN1; SMN2MAPTMAPK1RORC
SCHEMBL7123649 0.79 MEN1 (0.62) PPARGSMN1; SMN2MAPTMAPK1RORC
SCHEMBL7127748 0.79 SMN1; SMN2 (0.74) PPARGSMN1; SMN2MAPTMAPK1RORC
SCHEMBL7130551 0.79 RORC (0.82) PPARGSMN1; SMN2MAPTMAPK1RORC
SCHEMBL7128853 0.77 MAPT (0.62) PPARGSMN1; SMN2MAPTMAPK1RORC
SCHEMBL18147368 0.77 RORC (0.78) PPARGSMN1; SMN2MAPTMAPK1RORC
SCHEMBL7119934 0.76 RORC (0.73) PPARGSMN1; SMN2MAPTMAPK1RORC
SCHEMBL7120440 0.76 SMN1; SMN2 (0.81) PPARGSMN1; SMN2MAPTMAPK1RORC
SCHEMBL420231 0.75 RORC (1.00) PPARGSMN1; SMN2MAPTMAPK1RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD PPARG 1/4885SMN1; SMN2 3743/4885MAPT 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.